Generation Bio GBIO 深 滬
等待開盤 04-01 09:30:00 美东时间
5.34
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 5.34
- 總市值 3598.38万
- 52周最高 6.95
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.004
- 委 比 0.00%
- 總股本 673.85万
- 歷史最高 557.20
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.004
- 每 手 1
- 風險率 0.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多XOMA Royalty Completes Generation Bio Acquisition and Merger
Xoma ( ($XOMA) ) has provided an announcement. On February 6, 2026, XOMA Royalt...
02-10 05:56
XOMA Royalty übernimmt Generation Bio für 4,29 Dollar je Aktie
XOMA Royalty übernimmt Generation Bio für 4,29 Dollar je Aktie XOMA Royalty Corporation hat das Übernahmeangebot für alle ausstehenden Aktien von Generation Bio abgeschlossen und die Übernahme des Unternehmens vollzogen. Generation Bio-Aktionäre erhielten 4,2913 US-Dollar je Aktie in bar sowie eine
02-09 22:53
XOMA Royalty Completes Acquisition of Generation Bio for $4.29 Per Share
XOMA Royalty Completes Acquisition of Generation Bio for $4.29 Per Share XOMA Royalty Corporation has completed its previously announced acquisition of Generation Bio, Inc. The transaction followed a successful tender offer, with shareholders of Generation Bio receiving $4.2913 per share in cash plu
02-09 22:53
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
XOMA Royalty completed its acquisition of Generation Bio by paying $4.2913 per share in cash plus a contingent value right. Approximately 70% of shares were tendered, meeting the conditions for the takeover. Following the acquisition, Generation Bio merged into XOMA's subsidiary, becoming a wholly owned entity. Its shares ceased trading on Nasdaq and will be delisted.
02-09 14:53
Takeda, XOMA ink new royalty agreement; amend existing deal
XOMA Royalty Corporation (XOMA) on Tuesday announced that it reached a new royalty sharing transaction with Takeda (TAK) and amended its existing royalty sharing agreement for the Japanese drugmaker’s...
2025-12-30 21:14
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
BRIEF-Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member
Dec 16 (Reuters) - Generation Bio Co GBIO.O: NODTHERA APPOINTS GEOFF MCDONOUGH, M.D., AS INDEPENDENT BOARD MEMBER Source text: ID:nGNX9xQ43s Further company coverage: GBIO.O ((Reuters.Briefs@thomsonre...
2025-12-16 22:42
XOMA Royalty to acquire Generation Bio
XOMA Royalty (XOMA) has entered into an agreement to acquire Generation Bio (GBIO) for a cash price of $4.2913 per share. Generation Bio stockholders also will receive one non-transferable contingent ...
2025-12-16 06:28
XOMA Royalty To Acquire Generation Bio Co. For A Cash Price Of $4.2913 Per Share At The Closing Of The Merger
XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA), the biotech royalty aggregator, announced today it has entered into an agreement to acquire Generation Bio Co. ("Generation Bio") (NASDAQ:GBIO) for a cash price of
2025-12-16 06:02
XOMA Royalty Enters into Agreement to Acquire Generation Bio
<p>XOMA Royalty Corporation (XOMA Royalty) has agreed to acquire Generation Bio Co. (Generation Bio) for $4.2913 per share in cash. Generation Bio stockholders will also receive one non-transferable contingent value right (CVR) per share, entitling them to potential payments from net cash at closing, savings on lease obligations, proceeds from Generation Bio's license agreement with Moderna, and payments from out-licensing or selling Generation B...
2025-12-15 22:00
